Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COOLING COMPOUNDS
Document Type and Number:
WIPO Patent Application WO/2006/125334
Kind Code:
A1
Abstract:
A method of conferring a cooling effect on the skin or mucous membranes by applying thereto at least one compound of the Formula I: (a) wherein B is selected from H, CH3, C2H5, OCH3, OC2H5; and OH; and (b) wherein A is a moiety of the formula -CO-D, wherein D is selected from the following moieties: (i) -NR1R2, wherein R1 and R2 are independently selected from H and C1-C8 straight or branched-chain aliphatic, alkoxyalkyl, hydroxyalkyl, araliphatic and cycloalkyl groups, or R1 and R2 together with the nitrogen atom to which they are attached form part of an optionally-substituted, five- or six-membered heterocyclic ring; (ii) -NHCH2COOCH2CH3, -NHCH2CONH2, -NHCH2CH2OCH3, -NHCH2CH2OH, -NHCH2CH(OH)CH2OH and (iii) a moiety selected from the group consisting of: The compounds are useful for providing cooling effects in a variety of products, such as foodstuffs, confectionery, tobacco products, beverages, cosmetics, dentifrices, medicinal preparations, mouthwashes and toiletries.

Inventors:
BELL KAREN ANN (US)
FURRER STEFAN MICHAEL (US)
GALOPIN CHRISTOPHE (US)
KRAWEC PABLO VICTOR (US)
SLACK JAY PATRICK (US)
Application Number:
PCT/CH2006/000270
Publication Date:
November 30, 2006
Filing Date:
May 24, 2006
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GIVAUDAN SA (CH)
BELL KAREN ANN (US)
FURRER STEFAN MICHAEL (US)
GALOPIN CHRISTOPHE (US)
KRAWEC PABLO VICTOR (US)
SLACK JAY PATRICK (US)
International Classes:
A61K8/42; A23G3/00; A23L27/20; A24B15/34; A61K9/20; A61Q9/02; A61Q11/00; A61Q15/00; C07C233/57
Domestic Patent References:
WO2005020897A22005-03-10
WO2005049553A12005-06-02
Foreign References:
US20050084447A12005-04-21
US4226988A1980-10-07
Other References:
WATSON H R ET AL: "NEW COMPOUNDS WITH THE MENTHOL COOLING EFFECT", JOURNAL OF THE SOCIETY COSMETIC CHEMISTS, NEW-YORK, NY, US, vol. 29, no. 4, 1978, pages 185 - 200, XP009045124
Attorney, Agent or Firm:
Mcstea, John Anthony (Duebendorf, CH)
Download PDF:
Claims:
Claims:
1. A method of providing a cooling effect to the skin or mucous membranes, comprising the application thereto of at least one compound of formula I: (a) wherein B is selected from H, CH3, C2H5, OCH3, OC2H5; and OH; and (b) wherein A is a moiety of the formula COD, wherein D is selected from the following moieties: (i) NR1R2, wherein R1 and R2 are independently selected from H and C1C8 straight or branchedchain aliphatic, alkoxyalkyl, hydroxyalkyl, araliphatic and cycloalkyl groups, or R1 and R2 together with the nitrogen atom to which they are attached form part of an optionallysubstituted, five or sixmembered heterocyclic ring; (ii) NHCH2COOCH2CH3, NHCH2CONH2, NHCH2CH2OCH3, NHCH2CH2OH, NHCH2CH(OH)CH2OH and (iii) a moiety selected from the group consisting of: .
2. The method according to claim 1, wherein A is selected from the following: A is CONH2; and A is in the 4position and is CONHR3, wherein R3 is selected from a C1C4 straight or branchedchain aliphatic, alkoxyalkyl or hydroxyalkyl moiety.
3. The method according to claim 2, wherein B is H.
4. A product that provides a cooling effect to the skin or mucous membranes, comprising at least one compound of Formula I: (a) wherein B is selected from H, CH3, C2H5, OCH3, OC2H5; and OH; and (b) wherein A is a moiety of the formula COD, wherein D is selected from the following moieties: (i) NR1R2, wherein R1 and R2 are independently selected from H and C1C8 straight or branchedchain aliphatic, alkoxyalkyl, hydroxyalkyl, araliphatic and cycloalkyl groups, or R1 and R2 together with the nitrogen atom to which they are attached form part of an optionallysubstituted, five or sixmembered heterocyclic ring; (ii) NHCH2COOCH2CH3, NHCH2CONH2, NHCH2CH2OCH3, NHCH2CH2OH, NHCH2CH(OH)CH2OH and (iii) a moiety selected from the group consisting of: .
5. The product of claim 4, wherein A is selected from the following: A is CONH2; and A is in the 4position and is CONHR3, in which R3 is selected from a C1C4 straight or branchedchain aliphatic, alkoxyalkyl or hydroxyalkyl moiety.
6. The product of claim 5, wherein B is H.
7. The product of claim 4, wherein the product is at least one of foodstuffs, confectionery, tobacco products, beverages, cosmetics, dentifrices, medicinal preparations, mouthwashes or toiletries.
8. A compound comprising formula I: (a) wherein B is selected from H5 CH3, C2H5, OCH3, OC2H5; and OH; and (b) wherein A is a moiety of the formula COD, wherein D is selected from the following moieties: (i) NR1R2, wherein R1 and R2 are independently selected from H and C1Cg straight or branchedchain aliphatic, alkoxyalkyl, hydroxyalkyl, araliphatic and cycloalkyl groups, or R1 and R2 together with the nitrogen atom to which they are attached form part of an optionallysubstituted, five or sixmembered heterocyclic ring, with the proviso that, when B is H and A is CONH2, A is attached either to the 2or the 6position of the phenyl ring; (ii) NHCH2COOCH2CH3, NHCH2CONH2, NHCH2CH2OCH3, NHCH2CH2OH, NHCH2CH(OH)CH2OH and (iii) a moiety selected from the group consisting of: The compound of claim 8, wherein A is selected from the following: A is CONH2; and A is in the 4position and is CONHR3, in which R3 is selected from a C1C4 straight or branchedchain aliphatic, alkoxyalkyl or hydroxyalkyl moiety.
9. The compound of claim 9, wherein B is H.
Description:
COOLING COMPOUNDS

This invention relates to cooling compounds.

Cooling compounds, that is, chemical compounds that impart a cooling sensation to the skin or the mucous membranes of the body, are well known to the art and are widely used in a variety of products such as foodstuffs, confectionery, tobacco products, beverages, cosmetics, dentifrices, medicinal preparations, mouthwashes and toiletries.

One class of cooling compounds that haS enjoyed substantial success consists of N- substituted p-menthane carboxamides.

It has now been found that certain compounds exhibit a cooling effect that is both surprisingly strong and long-lasting. Therefore, a method is provided, which provides a cooling effect to the skin or mucous membranes and which comprises the application thereto of at least one compound of formula I:

(a) wherein B is selected from H, CH 3 , C 2 H 5 , OCH 3 , OC 2 H 5 ; and OH; and

(b) wherein A is a moiety of the formula -CO-D, wherein D is selected from the following moieties:

(i) -NR 1 R 2 , wherein R 1 and R 2 are independently selected from H and C 1 -C 8 straight or branched-chain aliphatic, alkoxyalkyl, hydroxyalkyl, araliphatic and cycloalkyl groups, or R 1 and R 2 together with the nitrogen atom to which they are attached form part of an optionally-substituted, five- or six-membered heterocyclic ring; (ii) -NHCH 2 COOCH 2 CH 3 , -NHCH 2 CONH 2 , -NHCH 2 CH 2 OCH 3 , -NHCH 2 CH 2 OH, -NHCH 2 CH(OH)CH 2 OH

Bestatigungskόplθ

and (iii) a moiety selected from the group consisting of:

A product is provided that provides a cooling effect to the skin or mucous membranes, comprising at least one compound of Formula I:

(a) wherein B is selected from H, CH 3 , C 2 H 5 , OCH 3 , OC 2 H 5 ; and OH; and

(b) wherein A is a moiety of the formula -CO-D, wherein D is selected from the following moieties:

(i) -NR 1 R 2 , wherein R 1 and R 2 are independently selected from H and C 1 -C 8 straight or branched-chain aliphatic, alkoxyalkyl, hydroxyalkyl, araliphatic and cycloalkyl groups, or R 1 and R 2 together with the nitrogen atom to which they are attached form part of an optionally-substituted, five- or six-membered heterocyclic ring; (ii) -NHCH 2 COOCH 2 CH 3 , -NHCH 2 CONH 2 , -NHCH 2 CH 2 OCH 3 , -NHCH 2 CH 2 OH, -NHCH 2 CH(OH)CH 2 OH and (iii) a moiety selected from the group consisting of:

A compound which comprises formula I is provided:

(a) wherein B is selected from H, CH 3 , C 2 H 5 , OCH 3 , OC 2 H 5 ; and OH; and

(b) wherein A is a moiety of the formula -CO-D, wherein D is selected from the following moieties:

(i) -NR 1 R 2 , wherein R 1 and R 2 are independently selected from H and C 1 -C 8 straight or branched-chain aliphatic, alkoxyalkyl, hydroxyalkyl, araliphatic and cycloalkyl groups, or R 1 and R 2

together with the nitrogen atom to which they are attached form part of an optionally-substituted, five- or six-membered heterocyclic ring, with the proviso that, when B is H and A is - CONH 2 , A is attached either to the 2-or the 6-position of the phenyl ring;

(ϋ) -NHCH 2 COOCH 2 CH 3 , -NHCH 2 CONH 2 , -NHCH 2 CH 2 OCH 3 , -NHCH 2 CH 2 OH, -NHCH 2 CH(OH)CH 2 OH and

(iii) a moiety selected from the group consisting of:

According to certain embodiments:

- A is -CONH 2 ; and

- A is in the 4-position and A is -CONHR 3 , R 3 being selected from a C 1 -C 4 straight or branched-chain aliphatic, alkoxyalkyl or hydroxyalkyl.

According to other embodiments:

- A is -CONH 2 ;

- A is in the 4-position and A is -CONHR 3 , R 3 being selected from a C 1 -C 4 straight or branched-chain aliphatic, alkoxyalkyl or hydroxyalkyl; and - B is H.

The compounds may be easily prepared and isolated by art-recognized methods.

Some of the compounds hereinabove described are available in a number of stereochemical forms. All possible stereochemical forms of the compounds hereinabove mentioned are encompassed by the scope of this invention.

They are distinguished from other cooling compounds of the prior art by their surprisingly high cooling effect (up to 10 times higher than that of known compounds) and by the longevity of the cooling effect, which adds to their attractiveness in a large variety of products.

For example, a small group of panelists was asked to taste various solutions of cooling compounds and indicate which solutions had a cooling intensity similar or slightly higher than that of a solution of menthol at 2ppm. Results are shown in Table 1.

Table 1 experiment on cooling intensity and longevity

From Table 1, it can be seen that the compounds of Formula I are up to 10 times stronger than menthol, the comparative cooling compound. Compounds of Formula I are also much stronger than WS-3, the best cooling compound of the prior art.

It is possible and permissible to blend two or more compounds useful in this invention. In addition, conventional cooling agents known to the art may also be used in conjunction with compositions according to this invention.

The compounds provided may be used in a wide variety of products that are applied to the mouth or the skin to give a cooling sensation. Such products include, but are not limited to, foodstuffs, confectionery, tobacco products, beverages, cosmetics, dentifrices, medicinal preparations, mouthwashes, toiletries, and the like. By "applying" it is meant any form of bringing into contact, for example, oral ingestion or, in the case of tobacco products, inhalation. In the case of application to the skin, it may be, for example, by including the compound in a cream or salve, sprayable composition, or like composition. Therefore, also provided is a product that provides a cooling effect to the skin or mucous membranes, which product comprises at least one compound as hereinabove described.

In further embodiments, novel compounds are provided. Therefore, provided is a compound of the formula I

(a) wherein B is selected from H, CH 3 , C 2 H 5 , OCH 3 , OC 2 H 5 ; and OH; and

(b) wherein A is a moiety of the formula -CO-D, wherein D is selected from the following moieties:

(i) -NR 1 R 2 , wherein R 1 and R 2 are independently selected from H and Ci-C 8 straight or branched-chain aliphatic, alkoxyalkyl, hydroxyalkyl, araliphatic and cycloalkyl groups, or R 1 and R 2 together with the nitrogen atom to which they are attached form part of an optionally-substituted, five- or six- membered heterocyclic ring, with the proviso that, when B is H and A is - CONH 2 , A is attached either to the 2-or the 6-position of the phenyl ring;

(iϊ) -NHCH 2 COOCH 2 CH 3 , -NHCH 2 CONH 2 , -NHCH 2 CH 2 OCH 3 , -NHCH 2 CH 2 OH, -NHCH 2 CH(OH)CH 2 OH, and

(iii) a moiety selected from the group consisting of:

EXPERIMENTAL 5

Listed below are non-limiting examples, which describe various embodiments.

Example 1

Preparation of N-(4-carboxamidophenyl) p-menthanecarboxamide

10 In a 4-L flask, 256g of p-aminobenzamide and 156g of pyridine were dissolved in

2.5 L of toluene. Under vigorous stirring, 586g of solution of p-menthanecarboxyl chloride at ~65% in toluene were added. The beige suspension was stirred vigorously overnight at room temperature. The suspension was filtered and the cake was washed with MTBE (tert- butyl methyl ether) and hot water. The product was recrystallized in ethanol to give 29Og of

15 white crystals of the desired product with the following spectroscopic properties: m.p.: 265-266°C

1 H NMR (300 MHz; d 6 -DMSO) δ: 9.86 (d, IH) 9 7.6 (m, 3H), 7.5 (m, 2H), 7.01 (br. d, IH), 2.87 (d, IH), 2.3 (d, IH), 2.14 (br. q, 2H) 1.81-1.32 (m, 5H), 1.16 (br. s, IH), 0.89 (d, 3H), 0.8-0.1 (m, 6H)

20 13 C NMR (75 MHz; d 6 -DMSO)δ: 174.1, 167.2, 141.7, 128.3, 128.0, 117.9, 48.5, 43.4, 34.0, 31.6, 28.2, 26.6, 23.3, 22.0, 21, 15.9. One peak around 39pρm is buried in the signal of DMSO.

Example 2 25 Preparation of N-(3-carboxamidophenyl) p-menthanecarboxamide

A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties:

1 H NMR (300 MHz; CDCl 3 ) δ: 9.00 (br. s, IH), 7.92 (s, IH), 7.78 (d, IH), 7.55 (d, 1 H), 7.36 (t, IH), 6.22 (br. s, IH), 3.39-3.11 (m, 2H), 2.29 (m, IH), 1.89-1.61 (m, 4H), 1.4-1.2 30 (m, 2H), 1.1-0.95 (m, 2H), 0.91 (d, 3H), 0.8 (d, 3H), 0.78 (d, 3H)

13 C NMR (75 MHz; CDCl 3 ) δ: 174.6, 168, 138.3, 133.6, 128.9, 123.3, 122.7, 118.6, 49.9, 44.0, 39.2, 34.3, 32.1, 28.6, 23.7, 22, 21.0, 15.8

Example 3 Preparation of N-(2-carboxamidophenyl) p-menthanecarboxamide

A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties: MS: 302([M + ']), 163, 136, 119, 83

1 H NMR (300 MHz; CDCl 3 ) δ: 11.27 (s, IH), 8.68 (d, IH), 7.56 (d, IH), 7.48 (t, 1 H), 7.05 (t, IH), 6.44 (br. s, IH), 5.89 (br. s, IH), 2.24 (td, IH), 1.92 (d, IH), 1.82-1.52 (m, 4H), 1.41 (br. s, IH), 1.35 (quintuplet, IH), 1.14-0.95 (m, 2H), 0.91 (d, 3H), 0.84 (d, 3H), 0.83 (d, 3H)

13 C NMR (300 MHz; CDCl 3 ) δ: 175.0, 171.1, 140.2, 133.1, 127.1, 122.2, 121.3, 118.2,

51.4, 44.5, 39.3, 34.4, 32.0, 28.7, 23.8, 22.1, 21.1, 15.9.

Example 4

Preparation of 4-[p-menthanecarbonyl-amino]-N-(2-methoxy-ethyl)-benzamide

A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties: MS: 360([M +* ]), 345, 328, 302, 286, 194, 162, 136, 120, 83

Example 5

Preparation of N-(4-(4-methylpiperazine-l-carbonyl)phenyl) p-menthanecarboxamide A preparation similar to that described in example 1 gives the desired product with the following spectroscopic properties: MS: 385 ([M +* ]), 370, 286, 120, 99, 83

Example 6

Application in Chewing gum

Gum Base Flama-T* 25.18O g

Compound of example 1 0. lOOg Peppermint oil 1.000 g

Corn Syrup 17.220 g

Sugar 55.17O g

Glycerine 1.330 g

*Flama-T is a trademark of Cafosa gum, Barcelona (Spain)

All the ingredients are mixed in the prewarmed gum base. The mixture is spread in thick films, cooled down and cut in sticks. A gum stick is chewed by a panelist for 15 minutes and spit out. When chewed, an agreeable cooling sensation was felt in all areas of the mouth. When spit out, the cooling sensation becomes intense and lasts for several hours

Example 7

Application in toothpaste

Opaque toothgel 99.500 g

Compound of example 3 as a 5% gel in Peppermint oil 0.500g

The chemicals are mixed in the toothgel, a piece of toothgel was put on a toothbrush and a panelist's teeth were brushed. The mouth was rinsed with water and the water was spit out. An intense cooling sensation was felt by the panelist in all areas of the mouth. The cooling perception lasted for several hours.

It will be understood that the embodiment(s) described herein is/are merely exemplary, and that one skilled in the art may make variations and modifications without departing from the spirit and scope of the invention. AU such variations and modifications are intended to be included within the scope of the invention as described hereinabove. Further, all embodiments disclosed are not necessarily in the alternative, as various embodiments of the invention may be combined to provide the desired result.